Ikarian Capital LLC 13D and 13G filings for Protara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:39 pm Sale | 2021-12-31 | 13G | Protara Therapeutics, Inc. TARA | Ikarian Capital LLC | 279,256 2.500% | -370,286 (-57.01%) | Filing |
| 2021-02-12 4:31 pm Purchase | 2020-12-31 | 13G | Protara Therapeutics, Inc. TARA | Ikarian Capital LLC | 649,542 5.800% | 649,542 (New Position) | Filing |